These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours. Bergman L; Boothroyd C; Palmer J; Grimmond S; Walters M; Teh B; Shepherd J; Hartley L; Hayward N Br J Cancer; 2000 Oct; 83(8):1003-8. PubMed ID: 10993646 [TBL] [Abstract][Full Text] [Related]
7. Allelic loss from chromosome 11 in parathyroid tumors. Friedman E; De Marco L; Gejman PV; Norton JA; Bale AE; Aurbach GD; Spiegel AM; Marx SJ Cancer Res; 1992 Dec; 52(24):6804-9. PubMed ID: 1360870 [TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1. Radford DM; Ashley SW; Wells SA; Gerhard DS Cancer Res; 1990 Oct; 50(20):6529-33. PubMed ID: 1976436 [TBL] [Abstract][Full Text] [Related]
9. Phosphatemia is related to chromosomal aberrations of parathyroid glands in patients with hyperparathyroidism. Chudek J; Nagy A; Kokot F; Podwinski A; Wiecek A; Ritz E; Kovacs G J Nephrol; 2007; 20(2):164-72. PubMed ID: 17514620 [TBL] [Abstract][Full Text] [Related]
10. Clonal analysis by chromosome 11 microsatellite-PCR of microdissected parathyroid tumors from MEN 1 patients. Morelli A; Falchetti A; Amorosi A; Tonelli F; Bearzi I; Ranaldi R; Tomassetti P; Brandi ML Biochem Biophys Res Commun; 1996 Oct; 227(3):736-42. PubMed ID: 8886003 [TBL] [Abstract][Full Text] [Related]
11. Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. Thakker RV; Pook MA; Wooding C; Boscaro M; Scanarini M; Clayton RN J Clin Invest; 1993 Jun; 91(6):2815-21. PubMed ID: 8514889 [TBL] [Abstract][Full Text] [Related]
12. Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism. Libutti SK; Crabtree JS; Lorang D; Burns AL; Mazzanti C; Hewitt SM; O'Connor S; Ward JM; Emmert-Buck MR; Remaley A; Miller M; Turner E; Alexander HR; Arnold A; Marx SJ; Collins FS; Spiegel AM Cancer Res; 2003 Nov; 63(22):8022-8. PubMed ID: 14633735 [TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases. Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929 [TBL] [Abstract][Full Text] [Related]
14. Morphology, DNA ploidy and allele losses on chromosome 11 in sporadic hyperparathyroidism and that associated with multiple neoplasia, type 1. Sandelin K; Larsson C; Falkmer UG; Farnebo LO; Grimelius L; Nordenskjöld M Eur J Surg; 1992 Apr; 158(4):199-206. PubMed ID: 1352132 [TBL] [Abstract][Full Text] [Related]
15. [Chromosome abnormalities in hyperparathyroidism: utility of comparative genomic hybridization in the study of parathyroid hyperplasias]. Afonso S; Cigudosa JC; Santamaría I; Otero A; Menárguez J; García Miranda JL Nefrologia; 2003; 23 Suppl 2():2-6. PubMed ID: 12778845 [TBL] [Abstract][Full Text] [Related]
16. Novel 14 base-pair deletion of the MEN1 gene in a patient with recurrent primary hyperparathyroidism. Katai M; Sakurai A; Uchino S; Minemura K; Hashizume K; Fukushima Y Jpn J Clin Oncol; 2006 Jun; 36(6):395-7. PubMed ID: 16714299 [TBL] [Abstract][Full Text] [Related]